MHE Staff

The U.S. Food and Drug Administration approved the second COVID-19 vaccine known as Moderna. The approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.

Perfect score from Human Rights Campaign Foundation highlights health company's commitment to LGBTQ+ equality.

A 2022 report by the Department of Labor cites specific examples of health plans and health insurance issuers failing to ensure parity. For instance, a health insurance issuer covered nutritional counseling for medical conditions like diabetes, but not for mental health conditions such as anorexia nervosa, bulimia nervosa and binge-eating disorder.

The global cancer immunotherapy market is set to grow at a compound annual growth rate, or CAGR, of 12.6% to $277.1 billion by 2030.

As the need for rapid tests increase, the nation's largest non-profit patient safety organization evaluated seven COVID-19 rapid tests and found serious gaps in their usability. Results shared that none of the tests were rated as excellent and some had noteworthy usability concerns.

CMS said in a press release that 13.6 million people had enrolled in ACA plans through Healthcare.gov and state-run exchanges.

New study shows opportunity exists to make healthcare more durable to further long-term gains in preparedness for emergencies like COVID-19.

COVID-19's latest variant, omicron, could increase the chance that folks will need a fourth vaccine dose earlier than expected, according to executives at Pfizer.

The COVID-19 pandemic has disrupted healthcare and many parts of the U.S. economy, but employer-based health insurance?

The Oncology Care Model (OCM) was CMS’ main attempt to usher value-based care into oncology. What will come after OCM is unclear as the future of successor, Oncology Care First, is now very much in doubt.

Now in winter, another variant and infections again on the rise, evidence abounds that COVID-19 isn’t finished plaguing, and normalcy’s still a long way off.

More than one quarter (27%) of employees with employer-sponsored health insurance said those expenses had a major impact on their mental health, while 16% indicated they had a major impact on their family’s well-being.

The adoption of healthcare IT leads as the main driver of growth.

Results from Year 6 of the Independence-at-Home demonstration project also did not show reductions in hospital admissions and emergency department visits.

U.S. workers plan to spend more time reviewing their healthcare options and enrolling in new benefits during this enrollment period

The decision on the fate of the novel therapy for hypertrophic cardiomyopathy was delayed because the agency said it needed more time to consider the risk evaluation and mitigation strategy (REMS) for the drug.

Seventy-one percent of healthcare executives agree that shifting home-based cancer care to their healthcare organizations as soon as possible will create "organizational success," according to a Reimagine Care survey.

The integration of virtual and in-person care, and expansion of mental health services is among the top health and well-being trends for next year.

Long term care industry facing worst job loss among all healthcare providers.

The medical cannabis market is expected to register a compound annual growth rate of 18.4% crossing the value of $33.2 Billion by 2027.

Dana Erickson, a senior vice president, is moving into the top job at the Blues plan after Craig Samitt, M.D., unexpectedly resigned earlier this year.

Brenden O'Hara, clinical pharmacist of Blue Cross Blue Shield of North Carolina, discusses innovations in diabetes management and what’s to come in 2022 at AMCP Nexus 2021.

Juday, director of specialty product development at CVS Health, shares how CBT’s for insomnia can save payers and can yield cost savings with or without a digital component.

A 4.7% increase in health benefit costs for 2022 is expected by employers of health plans as they focus on improving employee benefits rather than cost-cutting, according to a Mercer survey.

The Annual report shares actual cost trends and expectations for the future of healthcare.

Results from a survey conducted by DirectPath revealed many consumers still lack the knowledge required to make informed choices about their health plan and care, which displays as a concern for healthcare education and transparency.

Efforts are underway to accelerate the development of a novel therapy for excessive airway mucus and inflammation treatment for patients with chronic obstructive pulmonary disease and non-cystic fibrosis bronchiectasis.

A recent study reveals longstanding innovation operation issues create a deep-seated risk to corporate growth performance.

The organization expands existing initiatives to address systemic inequities with long-term, collaborative focus on community-based programs for serious chronic illness patients.